Genmab — April 2017
-
Det er rigtigt transalp..Karsten Ree mener, at Genmab er lidt længere fremme i udviklingen end Dandritt.
-
Det er dog muligt, at han ønsker at sammenlægge de to virksomheder, således at den ene ansatte fra Dandritt kan få noget løn.
-
bibob..Jeg vender tilbage senere i dag. Er arbejdsramt.
-
-
Breaking News! Ferrero to buy Genmab and also all rights to Darzalex from Janssen. Ferrero CEO, Gionanni Ferrero: "We will in the near future see Kinder Milchsnitte with Darzalex. Children will have Dazalex in the body before there are cancer cells and will attack them as soon as they appear. You can say that children who eat Kinder Milchsnitte will be cancer resistent"
-
Bo
rsen targets overview, starting offcourse with HSBC... http://borsen.dk/nyheder/virksomheder/artikel/1/342747/hsbc_vi_er_fan_af_genmab_men_venter_45_pct_kursdyk.html -
HSBC må have nogle ret bemærkelsesværdige forudsætninger i deres kalkule - de siger at GEN har en targetværdi på kurs 784 - eller dkk 47,5 mia. De regner med et topsalg på usd 10,5 mia, svarende til ca. dkk 13 mia royalty. en høkerudregning på de tal giver 47,5 mia / 13 mia = PE på 3,6
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind